Metabolite profiles and the risk of developing diabetes

Author(s): Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, et al.

Abstract

Emerging technologies allow the high-throughput profiling of metabolic status from a blood specimen (metabolomics). We investigated whether metabolite profiles could predict the development of diabetes. Among 2,422 normoglycemic individuals followed for 12 years, 201 developed diabetes. Amino acids, amines and other polar metabolites were profiled in baseline specimens by liquid chromatography-tandem mass spectrometry (LC-MS). Cases and controls were matched for age, body mass index and fasting glucose. Five branched-chain and aromatic amino acids had highly significant associations with future diabetes: isoleucine, leucine, valine, tyrosine and phenylalanine. A combination of three amino acids predicted future diabetes (with a more than fivefold higher risk for individuals in top quartile). The results were replicated in an independent, prospective cohort. These findings underscore the potential key role of amino acid metabolism early in the pathogenesis of diabetes and suggest that amino acid profiles could aid in diabetes risk assessment.

Similar Articles

The early natural history of nephropathy in Type 1 Diabetes: III

Author(s): Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, et al.

The pathogenesis of diabetic nephropathy

Author(s): Dronavalli S, Duka I, Bakris GL

Patterns of renal injury in NIDDM patients with microalbuminuria

Author(s): Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F, et al.

New and old markers of progression of diabetic nephropathy

Author(s): Jerums G, Premaratne E, Panagiotopoulos S, Clarke S, Power DA, et al.

Recent and potential developments of biofluid analyses in metabolomics

Author(s): Zhang A, Sun H, Wang P, Han Y, Wang X

A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human

Author(s): Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, et al.

A metabonomic comparison of urinary changes in Zucker and GK rats

Author(s): Zhao LC, Zhang XD, Liao SX, Gao HC, Wang HY, et al.

Scaling and normalization effects in NMR spectroscopic metabonomic data sets

Author(s): Craig A, Cloarec O, Holmes E, Nicholson JK, Lindon JC

Normalization of urinary drug concentrations with specific gravity and creatinine

Author(s): Cone EJ, Caplan YH, Moser F, Robert T, Shelby MK, et al.

Normalization strategies for metabonomic analysis of urine samples

Author(s): Warrack BM, Hnatyshyn S, Ott KH, Reily MD, Sanders M, et al.

Comprehensive profiling and quantitation of amine group containing metabolites

Author(s): Boughton BA, Callahan DL, Silva C, Bowne J, Nahid A, et al.

Proposed minimum reporting standards for data analysis in metabolomics

Author(s): Goodacre R, Broadhurst D, Smilde A, Kristal B, Baker J, et al.

A gentle guide to the analysis of metabolomic data

Author(s): Steuer R, Morgenthal K, Weckwerth W, Selbig J

Centering, scaling, and transformations: improving the biological information content of metabolomics data

Author(s): van den Berg RA, Hoefsloot HC, Westerhuis JA, Smilde AK, van der Werf MJ

Multiple hypothesis testing

Author(s): Shaffer JP

Comparison of specific gravity and creatinine for normalizing urinary reproductive hormone concentrations

Author(s): Miller RC, Brindle E, Holman DJ, Shofer J, Klein NA, et al.

Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes

Author(s): Lanza IR, Zhang S, Ward LE, Karakelides H, Raftery D, et al.

Taurine intestinal absorption and renal excretion test in diabetic patients: a pilot study

Author(s): Merheb M, Daher RT, Nasrallah M, Sabra R, Ziyadeh FN, et al.

Preventive effect of taurine on experimental type II diabetic nephropathy

Author(s): Lin S, Yang J, Wu G, Liu M, Luan X, et al.